Clinical Research Directory
Browse clinical research sites, groups, and studies.
Staccato Loxapine Thorough QT/QTc Study
Sponsor: Nova Pneuma Inc.
Summary
The purpose of the present Phase 1 study was to assess the cardiac safety of Staccato Loxapine administered to healthy volunteers in a 3 period crossover study.
Official title: Thorough QT/QTc Study of Staccato® Loxapine for Inhalation in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2009-04
Completion Date
2009-06
Last Updated
2026-04-22
Healthy Volunteers
Yes
Conditions
Interventions
Inhaled loxapine
Inhaled Staccato Loxapine 10 mg single dose
Inhaled placebo
Inhaled Staccato placebo single dose
Oral moxifloxacin
Oral moxifloxacin 400 mg
Oral placebo
Oral placebo similar in appearance to moxifloxacin 400 mg
Locations (1)
Covance Clinical Research Unit Inc.
Evansville, Indiana, United States